{"disease":{"id":"type-2-gaucher-disease","name":"type 2 gaucher disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05687474","title":"Baby Detect : Genomic Newborn Screening","phase":"","overall_status":"COMPLETED","enrollment_count":6824,"lead_sponsor_name":"Centre Hospitalier Universitaire de Liege","has_results":false},{"nct_id":"NCT04532047","title":"PEARL (PrEnAtal Enzyme Replacement Therapy for Lysosomal Storage Disorders)","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT00244582","title":"Convection-Enhanced Delivery of Glucocerebrosidase to Treat Type 2 Gaucher Disease","phase":"","overall_status":"COMPLETED","enrollment_count":1,"lead_sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}